New Approaches for Incorporating Genetic Diversity into Toxicity Testing (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-20-008 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports Phase I (R43), Direct to Phase II (R44), and Fast Track (R44) Small Business Innovative Research (SBIR) grant proposals from small businesses concerns (SBCs) to develop resources and approaches, including panels of cells or model organisms, that can better reflect the variability in human populations in chemical toxicity testing. Current toxicology testing is often limited to studies conducted in a small number of laboratory rodent strains, which can fail to identify clinically relevant tox...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 27, 2019 Category: Research Source Type: funding
Notice of Special Interest: Small Business Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones
Notice NOT-DK-20-002 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 6, 2019 Category: Research Source Type: funding
Notice of Special Interest: Small Business Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones
The purpose of this Notice is to inform potential applicants of an area of special interest in developing tools for continuous monitoring of circulating or interstitial nutrients, metabolites or hormones relevant to diet and nutrition.Christopher J. Lynch, Ph.D. | NOT-DK-20-002 (Source: NIDDK Funding Opportunities)
Source: NIDDK Funding Opportunities - November 6, 2019 Category: Endocrinology Source Type: funding
Organotypic Culture Models developed from Experimental Animals for Chemical Toxicity Screening (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-20-005 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports Phase I (R43), Phase II (R44), Direct Phase II (R44) and Fast Track (R44) Small Business Innovative Research (SBIR) grant proposals from small businesses concerns (SBCs) to develop novel, physiologically-relevant in vitro screening systems (e.g., engineered 3-dimensional or organotypic models) using cells derived from animal species typically utilized for toxicological testing, which will replicate biological interactions and toxicological responses observed in animal tissues or organs, wil...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 10, 2019 Category: Research Source Type: funding
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-20-011 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models foc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 4, 2019 Category: Research Source Type: funding
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)
Funding Opportunity RFA-NS-20-010 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models foc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 4, 2019 Category: Research Source Type: funding
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)
Funding Opportunity RFA-NS-20-008 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Technology Transfer (STTR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models foc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 4, 2019 Category: Research Source Type: funding
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-20-009 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Technology Transfer (STTR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models foc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 4, 2019 Category: Research Source Type: funding
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)
The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Technology Transfer (STTR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.RFA-NS-20-008 (Source:...
Source: NIDDK Funding Opportunities - October 4, 2019 Category: Endocrinology Source Type: funding
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Technology Transfer (STTR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.RFA-NS-20-009 (Source:...
Source: NIDDK Funding Opportunities - October 4, 2019 Category: Endocrinology Source Type: funding
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)
The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.RFA-NS-20-010 (Source:...
Source: NIDDK Funding Opportunities - October 4, 2019 Category: Endocrinology Source Type: funding
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.RFA-NS-20-011 (Source:...
Source: NIDDK Funding Opportunities - October 4, 2019 Category: Endocrinology Source Type: funding
Seeking Comments on Using Fast Healthcare Interoperability Resources for NIH-Supported Research
NIH
is currently accepting public comments on the use of standards for capturing, integrating,
and exchanging clinical data for research purposes (NOT-OD-19-150).
This is a great opportunity to hear more from the community on ways to
strengthen approaches that find, share, and access high-quality patient data,
while also making it more interoperable and reusable. Such goals align with
long-standing NIH
data sharing policies and what was also called for in a
related NIH strategic plan on
data science.
The
Request for Information focuses on the Fast
Healthcare Interoperability Resources (FHIR®) standard (see also NOT-OD-...
Source: NIH Extramural Nexus - September 30, 2019 Category: Research Authors: Mike Lauer Tags: blog Open Mike Uncategorized fast healthcare interoperability resources FHIR request for information Request For Information (RFI) Source Type: funding
NIH Blueprint for Neuroscience Research Education Program on Translational Devices (R25 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-20-003 from the NIH Guide for Grants and Contracts. This FOA solicits Research Education Grant (R25) applications to develop and implement a short course focused on (1) steps required for successful medical device development and translation, (2) common technical and strategic challenges, and (3) best-practices and resources for each stage in the process. Applicants may choose to include an extended mentorship plan if they see fit. The short course should address a broad audience, including senior post-doctoral fellows, independent academic researchers, clinician scientists, and small business...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 20, 2019 Category: Research Source Type: funding
Non-invasive Diagnostics to Improve Gynecologic Health (R43/R44 Clinical Trial Optional)
Funding Opportunity RFA-HD-20-019 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage small businesses to collaborate with scientists and clinicians in the field of gynecologic health to develop, advance, and validate new devices and methods for non-invasive diagnosis and/or screening of endometriosis, adenomyosis, and/or uterine fibroids. Projects supported will aim to shorten the time to diagnosis, decrease the invasiveness of current techniques, and/or improve accessibility, safety, convenience, and costs of diagnosis and/or screening. (Source: NIH F...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 17, 2019 Category: Research Source Type: funding
